Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Preprint Study Shows Increased Risk of Myocarditis Following Sequential COVID-19 Injections; Strongest Association in Males Under 40


A preprint released on December 25, 2021 analyzed the risk of myocarditis following multiple doses of the experimental COVID-19 injections. The study was conducted by UK researchers from institutions such as the University of Oxford, the University of Leicester, and the University of Edinburgh.

The researchers conducted a self-controlled case series analysis of over 42 million people age 13 or older. Their goal was to evaluate the association between COVID-19 inoculations and myocarditis. They categorized data by sex and age and included nearly 11 million people who received a third dose of the COVID-19 jabs.

The alarming results provide more evidence for regulators to halt these dangerous injections. The risk of myocarditis increased following multiple doses of the COVID-19 jabs, and the association was strongest in males under 40 years of age.

Could this be another indicator that explains why so many professional athletes are dropping on the playing surface to cardiac issues?

Read the Abstract from the preprint study titled “Risk of myocarditis following sequential COVID-19 vaccinations by age and sex

In an updated self-controlled case series analysis of 42,200,614 people aged 13 years or more, we evaluate the association between COVID-19 vaccination and myocarditis, stratified by age and sex, including 10,978,507 people receiving a third vaccine dose. Myocarditis risk was increased during 1-28 days following a third dose of BNT162b2 (IRR 2.02, 95%CI 1.40, 2.91). Associations were strongest in males younger than 40 years for all vaccine types with an additional 3 (95%CI 1, 5) and 12 (95% CI 1,17) events per million estimated in the 1-28 days following a first dose of BNT162b2 and mRNA-1273, respectively; 14 (95%CI 8, 17), 12 (95%CI 1, 7) and 101 (95%CI 95, 104) additional events following a second dose of ChAdOx1, BNT162b2 and mRNA-1273, respectively; and 13 (95%CI 7, 15) additional events following a third dose of BNT162b2, compared with 7 (95%CI 2, 11) additional events following COVID-19 infection. An association between COVID-19 infection and myocarditis was observed in all ages for both sexes but was substantially higher in those older than 40 years. These findings have important implications for public health and vaccination policy.



Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!